Characteristics ofBCR-ABLkinase domain mutations in chronic myeloid leukemia from India: not just missense mutations but insertions and deletions are also associated with TKI resistance-Reference-Cited by-同舟云学术

Characteristics ofBCR-ABLkinase domain mutations in chronic myeloid leukemia from India: not just missense mutations but insertions and deletions are also associated with TKI resistance

Published:2016-03-21 Issue:11 Volume:57 Page:2653-2660
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Patkar Nikhil,Ghodke Kiran,Joshi Swapnali,Chaudhary Shruti,Mascerhenas Russel,Dusseja Sona,Mahadik Shashikant,Gaware Sheetal,Tembhare Prashant,Gujral Sumeet,Kabre Sharayu,Kadam-Amare Pratibha,Jain Hasmukh,Dangi Uma,Bagal Bhausaheb,Khattry Navin,Sengar Manju,Arora Brijesh,Narula Gaurav,Banavali Shripad,Menon Hari,Subramanian Papagudi Ganesan

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

http://www.tandfonline.com/doi/pdf/10.3109/10428194.2016.1157868

Reference45 articles.

1. Imatinib Compared with Interferon and Low-Dose Cytarabine for Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia

2. Imatinib Mesylate — The New Gold Standard for Treatment of Chronic Myeloid Leukemia

3. Resistance to Tyrosine Kinase Inhibition Therapy for Chronic Myelogenous Leukemia: A Clinical Perspective and Emerging Treatment Options

4. Monitoring disease response to tyrosine kinase inhibitor therapy in CML

5. How I monitor residual disease in chronic myeloid leukemia

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Retrospective Analysis of BCR-ABL-1 Kinase Domain Mutations in Frontline TKI Resistant Chronic Myeloid Leukemia Patients: A Single Centre Experience;Indian Journal of Hematology and Blood Transfusion;2024-04-23

2. Disease Response Assessment Modalities in Chronic Myeloid Leukemia: Past, Present, and Future;Indian Journal of Medical and Paediatric Oncology;2023-11-27

3. Chronic myeloid leukemia kinase domain mutations: A retrospective descriptive study on the therapeutic and prognostic significance in patients at King Edward VIII Hospital, KwaZulu‐Natal, South Africa;Health Science Reports;2023-06-30

4. A Retrospective Analysis of BCR-ABL1 Kinase Domain Mutations in the Frontline Drug Intolerant or Resistant Chronic Myeloid Leukemia Patients: An Indian Experience from a High-End Referral Laboratory;South Asian Journal of Cancer;2022-12-31

5. Tyrosine kinase domain mutations in chronic myelogenous leukemia patients: Indian perspective;Journal of Postgraduate Medicine;2022